Mineralys Therapeutics Inc.
Clinical trials sponsored by Mineralys Therapeutics Inc., explained in plain language.
-
New pill aims to tame stubborn high blood pressure
Disease control CompletedThis study tested whether a new drug called lorundrostat, when added to a standard set of blood pressure medications, could help people whose high blood pressure was still not under control. About 285 adults with uncontrolled hypertension took either lorundrostat or a placebo (a …
Phase: PHASE2 • Sponsor: Mineralys Therapeutics Inc. • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New pill aims to tame sleep apnea and high blood pressure together
Disease control CompletedThis study tested whether a daily oral medication called lorundrostat could help adults who have both moderate-to-severe obstructive sleep apnea and high blood pressure. In this 48-person trial, participants took either the study drug or a placebo for four weeks, then switched af…
Phase: PHASE2 • Sponsor: Mineralys Therapeutics Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug shows promise for stubborn high blood pressure
Disease control CompletedThis large, completed Phase 3 trial tested whether a new drug called lorundrostat could lower blood pressure in people whose high blood pressure wasn't controlled despite taking 2 to 5 other medications. Over 1,000 participants were randomly assigned to receive either the new dru…
Phase: PHASE3 • Sponsor: Mineralys Therapeutics Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC